MedTech News
.................... by Andrew Celentano
Long COVID brain fog far more common in US than India, other nations
Large study of patients in U.S., Colombia, Nigeria and India finds symptom burden highest in high-income countries
Olympus launches single-use fine needle biopsy device in US
Olympus today announced the U.S. launch of its most advanced single-use fine needle biopsy device.
FDA clears eMurmur’s next-gen AI heart murmur detection software
eMurmur has received FDA 510(k) clearance for its next-generation heart murmur detection software, eMurmur Heart AI (2.2).
3D chip platform enables animal-free testing in cancer research
Cancer research laboratory tests can now be done using micro-physiological systems mimicking human physiology.
Lab-grown organoids reveal how glioblastoma outsmarts treatment
UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors in a setting that closely mirrors the human brain, shedding light on how the aggressive cancer interacts with surrounding brain cells and the immune system to become more invasive and resistant to therapy.
Smart contact lens with thin-film sensor enables real-time eye pressure monitoring
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (IOP) daily. The current tools for IOP measurement are not portable, convenient, easily accessible, or capable of continuous (24/7) monitoring.
New study finds heart attacks involve brain and immune system, not just heart
The conventional approach to studying and treating these episodes is to focus on the heart as an isolated organ. University of California San Diego research, led by the School of Biological Sciences, is upending the way heart attacks are viewed under a transformative new understanding of how cardiac events are interconnected with other systems.
Scientists develop first gene-editing treatment for skin conditions
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the University of British Columbia are extending those possibilities to the skin for the first time.